Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

MedCity Launched at Imperial College London

Published: Tuesday, April 08, 2014
Last Updated: Tuesday, April 08, 2014
Bookmark and Share
MedCity, a major new medical research and translation initiative, was launched at Imperial College London by the Mayor of London.

MedCity brings together the leading centres of medical research in London, Cambridge and Oxford as they work to translate their research into new healthcare applications for the benefit of patients and the economy. 

The new body, which is modelled on the successful Tech City Investment Organisation, will position the London-Oxford-Cambridge life sciences sector as a world-leading cluster that will match financial services in its importance to the UK economy.

MedCity has been established by the Mayor of London and Imperial College Academic Health Science Centre, King's Health Partners and UCL Partners with cooperation from the Universities of Cambridge and Oxford. The organisation's advisory board includes leading life sciences figures such as Imperial's Vice President (Health) Professor Dermot Kelleher, Sir Paul Nurse, Director of the Crick Institute, alongside successful entrepreneurs including Dr Hermann Hauser as well as leading political, medical and charitable representatives.

MedCity is funded by £2.92 million from the Higher Education Funding Council for England and £1.2 million from the Mayor of London's Office.

At the launch event held at Imperial's Hammersmith Campus - adjacent to the College's new research and innovation campus, Imperial West - Imperial College London joined forces with King's, UCL, Cambridge University and Oxford University, as well as charitable and commercial partners, to showcase cutting-edge healthcare applications.

A panel including Professor Jonathan Weber, Vice Dean of Medicine at Imperial, Lara Flynn, Vice President of Circassia, an Imperial College spinout valued at more than half a billion pounds, and the Mayor explored how the 'golden triangle' of scientific innovation can produce even greater benefits for the country's health and economy. 

Professor Dermot Kelleher, Vice President (Health) at Imperial College London, said:

"London is a world leader in medical research. Our unique combination of great universities and first-class research hospitals, dovetailed with access to a critical mass of entrepreneurial talent and a diverse population, puts the capital at the heart of medical discovery and its application. MedCity will allow us to intensify efforts to turn medical innovations into patient benefits and economic value on a national and international scale. 

"This collaboration will lay the foundations for the next generation of medical advances while helping secure the capital's long-term growth. London is powering ahead to a healthier and wealthier future." 

The Mayor of London, Boris Johnson, said: "Together with Oxford and Cambridge we form a 'golden triangle' of scientific innovation and we need to channel that intellectual pre-eminence into a positive impact on our economy. MedCity will span everything from research to clinical trials to manufacturing, across biotech, med tech and health tech. I am in no doubt that having the whole 'chain' from small spin-offs to massive companies doing their research, clinical development and manufacturing here in London and the south east can be as important to our economy as the financial services sector is today."

Professor David Gann, Vice-President (Development & Innovation) at Imperial College London, said: "MedCity will create jobs, attract new investment and accelerate the discovery of new healthcare applications. Imperial is ready to make a substantial contribution to this life sciences innovation ecosystem."

Just before the event, the Mayor visited Imanova: a pioneering imaging company formed by Imperial in collaboration with the Medical Research Council, UCL and King's.

Imanova Chief Executive Dr Kevin Cox and colleagues showed the Mayor how the company is translating cutting-edge medical research from leading universities like Imperial into commercial applications that are vastly improving brain and other scanning technology.

Dr Kevin Cox, CEO of Imanova, said: "Imanova is delighted to have hosted the Mayor's visit today. We are fully behind MedCity as it will position London as the undisputed leader for translational medicine in Europe; increasing inward investment, expanding collaborations and supporting growth. As a leading centre for imaging sciences this will greatly enhance Imanova's ability to attract business from around the world."

At Imanova, Boris Johnson used a novel device based on the Microsoft Kinect camera, which tracked his movements to generate a 3D image of the Mayor's head. This uses Imanova-developed software to track the movements of patients during their PET scan. The technique is particularly useful for patients who may find it difficult to keep still and ensures an accurate, unblurred brain scan is obtained.

Lord Ara Darzi, Professor of Surgery at Imperial and Chair of the London Health Commission said: "MedCity is an exciting initiative for London and the whole country.  My ambition for the Commission is to help London become the healthiest big city in the world and a successful and thriving life sciences sector is crucial to achieving this aim. During its call for evidence it has been clear to the Commission that with increased investment and collaboration the life sciences in London can make a bigger contribution to London's economy. The Commission will be working closely with MedCity as it develops its recommendations that I will present to the mayor in the autumn."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Genetic Form of Obesity and Diabetes Discovered
Scientists have discovered a new inherited form of obesity and type 2 diabetes in humans.
Tuesday, June 30, 2015
Researchers Develop New Breath Test to Diagnose Oesophageal and Gastric Cancer
Test will now be tested in a larger trial involving three hospitals in London.
Tuesday, June 23, 2015
DNA Sequencing Traces The Spread Of Drug-Resistant TB
Scientists have for the first time used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis between patients in the UK.
Monday, March 23, 2015
European Universities and Companies Form €2Bn Community to Promote Health
A consortium of 144 European companies, research institutes and universities has won EU backing to promote healthy living and active ageing.
Friday, December 12, 2014
Monitoring Effectiveness Of Hay Fever Immunotherapy
A new test for measuring histamine release from certain white blood cells could help doctors monitor the effectiveness of immunotherapy for hay fever.
Monday, November 24, 2014
Self-assembling Nanoparticle Could Improve MRI Scanning for Cancer Diagnosis
Scientists have designed the nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
Wednesday, July 16, 2014
New App Helps Patients Ensure Best Outcome from Surgery
MySurgery - New and innovative approach to reducing risk in surgery.
Thursday, July 03, 2014
Genetic Discovery Could Aid Diagnosis of Childhood TB
A distinctive genetic 'signature' found in the blood of children with TB offers new hope for improved diagnosis of the disease.
Thursday, May 01, 2014
Improved Diagnostic Technology may Obviate Need for Unpleasant Drug
A new method for measuring narrowing in the arteries of the heart may allow patients to be assessed for a stent without having to take a drug with unpleasant side effects.
Thursday, December 08, 2011
Blood Clotting Finding may Lead to New Treatments
Researchers find that a key protein that causes the blood to clot is produced by blood vessels in the lungs and not just the liver.
Thursday, February 11, 2010
Scientific News
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
New Test Detects All Viruses
A new test detects virtually any virus that infects people and animals, according to research at Washington University School of Medicine in St. Louis, where the technology was developed.
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
Chip-Based Technology Enables Reliable Direct Detection of Ebola Virus
Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA.
Diagnostics Breakthrough Brings Viral Sequencing to Doctors’ Toolkit
New screening tool produces up to 10,000-fold improvement in viral matches compared with traditional high-throughput methods.
New Cell Type May Help Explain Dangerous Food Allergies
Researchers have discovered a new cell type that appears to drive life-threatening food allergies and may help explain why some people get severe allergic reactions and others do not.
Molecular Diagnostics At Home
Electrochemical test's sensing principle may be generalized to many different targets, leading to inexpensive devices that could detect dozens of disease markers in less than 5 minutes.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos